EUVIMEDEUVIMED entdecken
Crossref

Overexpression of blaGES-1 due to a strong promoter in the class 1 integron contributes to decreased ceftazidime-avibactam susceptibility in carbapenem-resistant Pseudomonas aeruginosa ST235

Xi Li, Xiaofan Zhang, Heng Cai, Yiwei Zhu, Jingshu Ji, Tingting Qu, Yuexing Tu, Hua Zhou, Yunsong Yu

Drug Resistance Updates · 2023

DOI: 10.1016/j.drup.2023.100973 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2023. Verfasst von Xi Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Laboratory Medicine, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical Colleg…. Hauptthemen laut MEDLINE: Drug Resistance, Multiple, Bacterial, Pseudomonas aeruginosa. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sequence type 235 (ST235) Pseudomonas aeruginosa, harboring so-called international, high-risk, or widespread clones, is associated with relatively high morbidity and mortality, partly due to multiantibiotic and high-level antibiotic resistance. Treatment of infections caused by such strains with ceftazidime-avibactam (CZA) is often successful. However, CZA resistance in carbapenem-resistant P. aeruginosa (CRPA) strains has been consistently reported with the increasing use of this drug. Likewise, we identified thirty-seven CZA-resistant ST235 P. aeruginosa strains from among 872 CRPA isolates. A total of 10.8% of the ST235 CRPA strains were resistant to CZA. Site-directed mutagenesis, cloning, expression, and whole-genome sequencing analysis revealed that overexpression of blaGES-1, which was carried in a class 1 integron of the complex transposon Tn6584, occurred due to a strong promoter, contributing to CZA resistance. Moreover, such overexpression of blaGES-1 combined with an efflux pump resulted in high-level resistance to CZA, considerably reducing the therapeutic options available for treating infections caused by ST235 CRPA. Considering the widespread presence of ST235 P. aeruginosa strains, clinicians should be aware of the risk of CZA resistance development in high-risk ST235 P. aeruginosa. Surveillance initiatives for preventing further dissemination of high-risk ST235 CRPA isolates with CZA resistance are essential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, Multiple, BacterialPseudomonas aeruginosaAnti-Bacterial Agentsbeta-LactamasesCarbapenemsIntegronsMicrobial Sensitivity TestsPseudomonas InfectionsCeftazidimeDrug CombinationsAzabicyclo Compounds

Stichwörter der Autor:innen

CRPA, ST235Efflux pumpIntegronbla(GES-1)

Substanzen

Anti-Bacterial Agentsbeta-LactamasesCarbapenemsavibactam, ceftazidime drug combinationCeftazidimeDrug CombinationsAzabicyclo Compounds

Autor:innen und Institutionen

  • Centre of Laboratory Medicine, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, 158 Shangtang Road, Hangzhou, Zhejiang 310014, China.
  • Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China.
  • Department of Critical Care Medicine, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Di…
  • Department of Critical Care Medicine, Tongde Hospital of Zhejiang Province, #234 Gucui Road, Hangzhou, Zhejiang 310012, China. Electronic address: tuyuexing@hmc.edu.cn.
  • Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China. Electronic address: zhouhua1@zju.edu.cn.

Zitieren

APA

Li, X., Zhang, X., Cai, H., Zhu, Y., Ji, J., Qu, T., Tu, Y., Zhou, H., & Yu, Y. (2023). Overexpression of blaGES-1 due to a strong promoter in the class 1 integron contributes to decreased ceftazidime-avibactam susceptibility in carbapenem-resistant Pseudomonas aeruginosa ST235. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2023.100973

Vancouver

Li X, Zhang X, Cai H, Zhu Y, Ji J, Qu T, et al. Overexpression of blaGES-1 due to a strong promoter in the class 1 integron contributes to decreased ceftazidime-avibactam susceptibility in carbapenem-resistant Pseudomonas aeruginosa ST235. Drug Resistance Updates. 2023. doi:10.1016/j.drup.2023.100973

BibTeX
@article{Li2023,
  author = {Li, Xi and Zhang, Xiaofan and Cai, Heng and Zhu, Yiwei and Ji, Jingshu and Qu, Tingting and Tu, Yuexing and Zhou, Hua and Yu, Yunsong},
  title = {Overexpression of blaGES-1 due to a strong promoter in the class 1 integron contributes to decreased ceftazidime-avibactam susceptibility in carbapenem-resistant Pseudomonas aeruginosa ST235},
  journal = {Drug Resistance Updates},
  year = {2023},
  doi = {10.1016/j.drup.2023.100973}
}
Kostenlos starten →